Jacques Rohayem
Has participated in:
-
Autoantikörper gegen p53 und das tumorassoziierte inhibitor of apoptosis Protein Survivin bei Tumorpatienten
-
PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy
-
Chlorpromazine Combined with Cidofovir for Treatment of a Patient Suffering from Progressive Multifocal Leukoencephalopathy